Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
PBCAR-20A by Precision Biosciences for Refractory Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
PBCAR-20A is under clinical development by Precision Biosciences and currently in Phase II for Refractory Chronic Lymphocytic Leukemia (CLL). According...
Data Insights
PBCAR-20A by Precision Biosciences for Relapsed Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
PBCAR-20A is under clinical development by Precision Biosciences and currently in Phase II for Relapsed Chronic Lymphocytic Leukemia (CLL). According...